Watch VideoAmerican drugmaker Merck is purchasing Austrian vaccine maker Themis and joining the race for a coronavirus vaccine. Merck also plans to collaborate with a nonprofit research organization to develop a second vaccine.
The president of Merck Research Laboratories said of purchasing Themis, “We are eager to combine...
U.S. Drugmaker Merck Enters Vaccine Race With 2 New Partnerships
Newsy
0 shares
1 views